Kidney Disease, Earnings Announcements
Rockwell Medical Technologies Inc
Rockwell Medical Technologies Inc. reported record fourth quarter 2007 sales of $11.95 million, up 29.5% as compared to $9.2 million for the same period of 2006. Loss for the fourth quarter was $1,162,843 or $0.09 per share compared with $1,155,035 or $0.10 for the same period of 2006.
- Login to post comments
PDL BioPharma Inc.
PDL BioPharma Inc. reported earnings results for the fourth quarter and full year ended December 31, 2007. Total revenues for the fourth quarter of 2007 were $49.8 million compared to $59.8 million in the same period of 2006.
Cantel Medical Corp.
Cantel Medical Corp. reported earnings results for the second quarter ended January 31, 2008. For the quarter, the Company reported net income of $2,157,000 or $0.13 per diluted share, on net sales of $60,910,000 compared to net income of $2,270,000 or $0.14 per diluted share, on net sales of $51,635,000 for the same period last year.
- Login to post comments
Neose Technologies Inc
Neose Technologies Inc. announced earnings results for the fourth quarter and year ended December 31, 2007. For the quarter, the company reported a net loss of $3.2 million, or $0.06 per basic and diluted share, compared to a net loss of $9.5 million, or $0.29 per basic and diluted share, for the same period in 2006. Revenues for the fourth quarter of 2007 were $2.7 million compared to $0.6 million for the fourth quarter of 2006.
- Login to post comments
Dialysis Corp. of America
Dialysis Corp. of America reported earnings results for the fourth quarter and year ended December 31, 2007. Year end patient census from owned and managed centers approximated 1,750, resulting in operating revenues for the fourth quarter of 2007 of $19,986,000 compared to $18,199,000 for the same period last year, a 10% increase.
Affymax Inc.
Affymax Inc. reported earnings results for the fourth quarter and full year ended December 31, 2007. For the quarter, the company reported wider loss despite a big boost in revenue resulting a partnership with another drug company to develop a compound. For the quarter ended Dec. 31, the company reported a loss of $13.9 million, or 92 cents per share, compared with a loss of $7.8 million, or $2.49 per share in the prior-year quarter.
Shire plc
Shire plc reported earnings results for the year ended December 31, 2007. For the period, the company reported profit of $82.4 million or 15.0 cents per diluted share on revenue of $2,436.3 million against profit of $56.2 million or 11.0 cents per diluted share on revenue of $1,796.5 million for the same period in the previous year.
ProMetic Life Sciences Inc
ProMetic Life Sciences Inc. reported earnings results for the full year ended December 31, 2007. For the period, the company reported total revenues, which were derived from the protein technology unit, were $8.4 million compared with $2.6 million in 2006. In addition, as at December 31, 2007, deferred revenues were at $1.6 million.
Nephros Inc.
Nephros Inc. reported earnings results for the fourth quarter and year ended December 31, 2007. For the quarter, the company reported product revenues of $441,000, attributable to sales of its OLpur(TM) MD190 and MD220 products in Europe, compared with $153,000 in the corresponding period of 2006, an increase of 188%.
Neose Technologies Inc
Neose Technologies Inc. announced earnings results for the fourth quarter and year ended December 31, 2007. For the quarter, the company reported a net loss of $3.2 million, or $0.06 per basic and diluted share, compared to a net loss of $9.5 million, or $0.29 per basic and diluted share, for the same period in 2006.
